Simcere Pharmaceutical Group Limited
2096Pharmaceuticals
HK$10.38+0.68%As of Oct 29vs prior close
- Market cap
- $3.4B
- P/E (TTM)
- 14.3×
- P/E (FY1)
- 13.0×
- From 52W high
- −24.39%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥8.7B
- Net margin
- 18.01%
- Dividend yield
- 1.99%
Nomior Score
53
Steady ProfileTop 44% of the scored universe
Growth51
Quality62
Value53
Momentum42
Resilience53
Growth
+6.93%revenue a year over 3 fiscal years
YE22 CN¥6.3BLTM CN¥8.7B
Connections
Revenue to profitYE25
17% of revenue became net profit, up 7 pts on a year.